These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 32031663

  • 1. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):2764-2773. PubMed ID: 32031663
    [Abstract] [Full Text] [Related]

  • 2. Risk of adrenal insufficiency in patients with polymyalgia rheumatica versus patients with rheumatoid arthritis: A cross-sectional study.
    Kasahara A, Kida T, Hirano A, Omura S, Sofue H, Sakashita A, Sagawa T, Asano M, Fukui M, Wada M, Kohno M, Kawahito Y.
    Mod Rheumatol; 2022 Aug 20; 32(5):891-898. PubMed ID: 35041750
    [Abstract] [Full Text] [Related]

  • 3. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 20; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 4. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzorni C, Seriolo B, Salvarani C.
    J Rheumatol; 2002 Apr 20; 29(4):748-56. PubMed ID: 11950017
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
    Emamifar A, Ellingsen T, Hermann AP, Hess S, Gerke O, Ahangarani Farahani Z, Syrak Hansen P, Jensen Hansen IM, Thye-Rønn P.
    Sci Rep; 2021 Mar 18; 11(1):6220. PubMed ID: 33737697
    [Abstract] [Full Text] [Related]

  • 6. Comment on: Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis - prevalence and clinical approach.
    Ješe R, Ambrožič A, Markez S, Tomšič M, Hočevar A.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):e77. PubMed ID: 32756997
    [No Abstract] [Full Text] [Related]

  • 7. Comment on: Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach: reply.
    Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):e78. PubMed ID: 32756990
    [No Abstract] [Full Text] [Related]

  • 8. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    Manning JE, Harris E, Mathieson H, Sorensen L, Luqmani R, McGettrick HM, Morgan AW, Young SP, Mackie SL.
    J Autoimmun; 2024 Jul 01; 147():103260. PubMed ID: 38797046
    [Abstract] [Full Text] [Related]

  • 9. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD.
    J Rheumatol; 2009 Oct 01; 36(10):2269-76. PubMed ID: 19684157
    [Abstract] [Full Text] [Related]

  • 10. Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.
    Wu J, Keeley A, Mallen C, Morgan AW, Pujades-Rodriguez M.
    CMAJ; 2019 Jun 24; 191(25):E680-E688. PubMed ID: 31235489
    [Abstract] [Full Text] [Related]

  • 11. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.
    JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619
    [Abstract] [Full Text] [Related]

  • 12. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A, Hess S, Gerke O, Hermann AP, Laustrup H, Hansen PS, Thye-Rønn P, Marcussen N, Svendstrup F, Gildberg-Mortensen R, Bang JC, Farahani ZA, Chrysidis S, Toftegaard P, Andreasen RA, le Greves S, Andersen HR, Olsen RN, Hansen IMJ.
    Medicine (Baltimore); 2017 Jun 14; 96(26):e7297. PubMed ID: 28658131
    [Abstract] [Full Text] [Related]

  • 13. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
    Esen I, Arends S, Dalsgaard Nielsen B, Therkildsen P, Hansen I, van 't Ende A, Heeringa P, Boots A, Hauge E, Brouwer E, van Sleen Y.
    RMD Open; 2023 Jan 14; 9(1):. PubMed ID: 36631159
    [Abstract] [Full Text] [Related]

  • 14. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
    Kyle V, Hazleman BL.
    Ann Rheum Dis; 1989 Aug 14; 48(8):658-61. PubMed ID: 2782975
    [Abstract] [Full Text] [Related]

  • 15. Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
    Diamantopoulos AP, Hetland H, Myklebust G.
    Biomed Res Int; 2013 Aug 14; 2013():120638. PubMed ID: 24106691
    [Abstract] [Full Text] [Related]

  • 16. Polymyalgia rheumatica and its links with giant cell arteritis.
    Charlton R.
    Clin Med (Lond); 2008 Oct 14; 8(5):498-501. PubMed ID: 18975481
    [Abstract] [Full Text] [Related]

  • 17. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR, Athanasiov PA, Crompton JL.
    Aust Fam Physician; 2006 Nov 14; 35(11):889-91. PubMed ID: 17099810
    [Abstract] [Full Text] [Related]

  • 18. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J, Klareskog L, Hjalgrim H, Baecklund E, Björkholm M, Ekbom A.
    Ann Rheum Dis; 2005 Dec 14; 64(12):1765-8. PubMed ID: 15843445
    [Abstract] [Full Text] [Related]

  • 19. Treatment of polymyalgia rheumatica/giant cell arteritis.
    Kyle V.
    Baillieres Clin Rheumatol; 1991 Dec 14; 5(3):485-91. PubMed ID: 1807823
    [Abstract] [Full Text] [Related]

  • 20. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A.
    Ann Rheum Dis; 2024 Feb 15; 83(3):335-341. PubMed ID: 37932008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.